Related Experiment Video

Updated: Aug 12, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Sequelae of meningococcal disease - studied about six weeks after hospital admission

G Djupesland, T W Gedde-Dahl

    NIPH Annals
    |June 1, 1983
    PubMed

    Insights

    Meningococcal disease (MCd) can lead to significant sequelae in about 18% of cases. Routine follow-up examinations are crucial for patient care and research into better treatments and prophylaxis.

    Area of Science:

    • Infectious Diseases
    • Neurology
    • Public Health

    Background:

    • Meningococcal disease (MCd) is a serious infection with potential long-term health consequences.
    • Understanding the frequency and type of sequelae is vital for patient management and public health strategies.
    • The MenOPP project aims to comprehensively assess outcomes following MCd.

    Purpose of the Study:

    • To estimate the type, distribution, and frequency of sequelae following meningococcal disease.
    • To compare sequelae rates in MCd patients with control groups, including those with other bacterial meningitis/septicemia.
    • To evaluate the utility of routine follow-up examinations for MCd survivors.

    Main Methods:

    • Prospective cohort study involving 102 patients with MCd and control groups.
    • Examinations conducted approximately six weeks after hospital admission.
    • Systematic documentation and classification of sequelae.

    Main Results:

    • Approximately 18% of MCd patients exhibited well-documented sequelae.
    • Control groups showed lower sequelae rates (3% in general controls, 11% in other bacterial meningitis/septicemia controls).
    • Uncertain sequelae rates were similar between MCd and control groups (16%).

    Conclusions:

    • Meningococcal disease is associated with a substantial burden of sequelae.
    • Routine follow-up examinations at six weeks and one year post-MCd are recommended for patient assessment.
    • Findings support ongoing research for improved MCd prophylaxis and treatment strategies.

    More Related Videos

    Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression07:30

    Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

    Published on: June 15, 2019

    Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

    Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

    Published on: November 5, 2019

    Related Concept Videos

    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Viral Meningitis01:18

    Viral Meningitis

    Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...